Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
SR One Capital Management, LLC reported a 9.30% stake in Adarx Pharmaceuticals, Inc. (Schedule 13D)
Event Sep 28, 2026 · Filed Oct 5, 2026
SR One Capital Management, LLC reported a 9.30% stake in Adarx Pharmaceuticals, Inc., 9,936,661 shares, with active intent on Sep 28, 2026. Filed Oct 5, 2026 (Schedule 13D).
- Stake
- 9.30%
- Shares
- 9,936,661
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SR One Capital Management, LLC | 9.30% | 9,936,661 |
| SR One Capital Fund I Aggregator, LP | 5.20% | 5,554,094 |
| SR One Capital Partners I, LP | 5.20% | 5,554,094 |
| SR One Capital Opportunities Fund I, LP | 1.80% | 1,953,505 |
| SR One Capital Opportunities Partners I, LP | 1.80% | 1,953,505 |
| SR One Co-Invest III, LLC | 1.70% | 1,836,469 |
| SR One Co-Invest III Manager, LLC | 1.70% | 1,836,469 |
| AMZL, LP | 0.60% | 592,593 |
| SR One Capital SMA Partners, LP | 0.60% | 592,593 |
| Simeon George | 9.30% | 9,936,661 |
Source
Related
- Adarx Pharmaceuticals, Inc.
- SR One Capital Management, LLC
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Chimovits Erez · Sep 30, 2026
- Form 4 · Gordon Carl L · Sep 30, 2026